A detailed history of Charles Schwab Investment Management Inc transactions in Catalent, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,656,506 shares of CTLT stock, worth $97.7 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,656,506
Previous 1,638,825 1.08%
Holding current value
$97.7 Million
Previous $92.2 Million 8.88%
% of portfolio
0.02%
Previous 0.02%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$56.16 - $60.96 $992,964 - $1.08 Million
17,681 Added 1.08%
1,656,506 $100 Million
Q2 2024

Aug 12, 2024

BUY
$53.58 - $57.02 $1.43 Million - $1.52 Million
26,688 Added 1.66%
1,638,825 $92.2 Million
Q1 2024

May 08, 2024

BUY
$42.56 - $59.82 $2.2 Million - $3.09 Million
51,667 Added 3.31%
1,612,137 $91 Million
Q4 2023

Feb 06, 2024

BUY
$32.18 - $46.57 $777,372 - $1.12 Million
24,157 Added 1.57%
1,560,470 $70.1 Million
Q3 2023

Nov 08, 2023

BUY
$44.2 - $50.2 $22.8 Million - $25.9 Million
516,464 Added 50.64%
1,536,313 $69.9 Million
Q2 2023

Aug 09, 2023

BUY
$31.86 - $67.26 $749,410 - $1.58 Million
23,522 Added 2.36%
1,019,849 $44.2 Million
Q1 2023

May 11, 2023

SELL
$45.44 - $74.26 $6.34 Million - $10.4 Million
-139,533 Reduced 12.28%
996,327 $65.5 Million
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $4.17 Million - $8.17 Million
100,816 Added 9.74%
1,135,860 $51.1 Million
Q3 2022

Nov 14, 2022

BUY
$72.36 - $113.1 $7.1 Million - $11.1 Million
98,160 Added 10.48%
1,035,044 $74.9 Million
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $2.2 Million - $2.88 Million
25,223 Added 2.77%
936,884 $101 Million
Q1 2022

May 13, 2022

BUY
$94.19 - $124.49 $6.71 Million - $8.87 Million
71,290 Added 8.48%
911,661 $101 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $3.18 Million - $3.7 Million
26,619 Added 3.27%
840,371 $108 Million
Q3 2021

Nov 16, 2021

BUY
$109.17 - $142.35 $1.41 Million - $1.84 Million
12,911 Added 1.61%
813,752 $108 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $2.36 Million - $2.72 Million
23,527 Added 3.03%
800,841 $86.6 Million
Q1 2021

May 17, 2021

SELL
$101.51 - $125.27 $2.82 Million - $3.48 Million
-27,807 Reduced 3.45%
777,314 $81.9 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $493,638 - $605,609
5,748 Added 0.72%
805,121 $83.8 Million
Q3 2020

Nov 13, 2020

SELL
$72.74 - $92.5 $9.39 Million - $11.9 Million
-129,061 Reduced 13.9%
799,373 $68.5 Million
Q2 2020

Aug 14, 2020

SELL
$48.02 - $79.04 $242,789 - $399,626
-5,056 Reduced 0.54%
928,434 $68.1 Million
Q1 2020

May 15, 2020

BUY
$36.95 - $62.95 $2.56 Million - $4.36 Million
69,219 Added 8.01%
933,490 $48.5 Million
Q4 2019

Feb 07, 2020

BUY
$47.06 - $56.64 $202,075 - $243,212
4,294 Added 0.5%
864,271 $48.7 Million
Q3 2019

Nov 08, 2019

SELL
$47.45 - $58.05 $9.05 Million - $11.1 Million
-190,796 Reduced 18.16%
859,977 $41 Million
Q2 2019

Aug 09, 2019

BUY
$39.26 - $54.21 $109,928 - $151,788
2,800 Added 0.27%
1,050,773 $57 Million
Q1 2019

May 14, 2019

BUY
$29.84 - $43.92 $2.37 Million - $3.49 Million
79,474 Added 8.21%
1,047,973 $42.5 Million
Q4 2018

Feb 14, 2019

SELL
$29.95 - $46.34 $4.07 Million - $6.3 Million
-136,016 Reduced 12.31%
968,499 $30.2 Million
Q3 2018

Nov 13, 2018

BUY
$40.12 - $45.55 $1.18 Million - $1.34 Million
29,472 Added 2.74%
1,104,515 $50.3 Million
Q2 2018

Aug 08, 2018

SELL
$38.72 - $42.52 $7.14 Million - $7.84 Million
-184,397 Reduced 14.64%
1,075,043 $45 Million
Q1 2018

May 07, 2018

BUY
$39.4 - $47.39 $3.02 Million - $3.63 Million
76,670 Added 6.48%
1,259,440 $51.7 Million
Q4 2017

Jan 17, 2018

BUY
$37.27 - $43.02 $5.08 Million - $5.87 Million
136,353 Added 13.03%
1,182,770 $48.6 Million
Q3 2017

Nov 13, 2017

BUY
$33.75 - $41.67 $35.3 Million - $43.6 Million
1,046,417
1,046,417 $41.8 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.6B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.